Protocol for a multicenter prospective sequential intervention study: the effect of adaptive closed-loop postural training on gait disorders in hemiparetic stroke patients

一项多中心前瞻性序贯干预研究方案:自适应闭环姿势训练对偏瘫卒中患者步态障碍的影响

阅读:1

Abstract

INTRODUCTION: Stroke often leads to hemiparetic gait, which negatively affects the quality of life and increases socioeconomic burdens. Conventional therapies have limited effectiveness in improving gait. Postural regulation deficits are a key factor contributing to gait disorders. The Gusu Constraint Standing Training (GCST), a novel posture adjustment approach, shows promise in improving central gait disorders. We hypothesize that GCST optimizes gait in hemiparetic stroke patients by enhancing their postural adaptation criticality and improving gait control through the common neural pathways and nodes shared by posture and gait. However, the specific effects and underlying mechanisms of GCST require further study. METHODS AND ANALYSIS: This multicenter, prospective, sequential study will recruit 180 hemiparetic stroke patients (recovery phase: 3-6 months; chronic phase: ≥6 months post-stroke) across four hospitals, along with 30 healthy controls. GCST is divided into a structured, stepwise intervention (steps A-E) implemented sequentially based on predefined performance criteria. Assessments will be conducted at baseline, after the completion of each intervention step, and at follow-ups. The primary outcome is the minimal knee flexion angle of the hemiparetic limb during the swing phase, quantified using the three-dimensional gait analysis. Secondary outcomes include gait, postural, neuromuscular, and functional measures. Outcome assessors will be blinded to participants' stroke phase. Longitudinal data will be analyzed using linear mixed-effects models. Healthy controls will provide normative reference values. ETHICS AND DISSEMINATION: Approved by each hospital's ethics committees, the study will require informed consent from participants. The results will be shared through academic conferences and peer-reviewed journals while ensuring participant confidentiality. CLINCIAL TRIAL REGISTRATION: https://www.chictr.org.cn/showproj.html?proj=235182, Identifier ChiCTR2400094903.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。